Aussie giant takes $17b hit as more Americans shun vaccines
A plunge in US vaccination rates, which has occurred since the appointment of vaccine sceptic health secretary Robert F. Kennedy, sparked a fresh earnings blow to biotech giant CSL.
Read original
Sydney Morning Herald